A detailed history of Coastwise Capital Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Coastwise Capital Group, LLC holds 1,374 shares of ABBV stock, worth $238,540. This represents 0.24% of its overall portfolio holdings.

Number of Shares
1,374
Previous 1,365 0.66%
Holding current value
$238,540
Previous $211,000 18.48%
% of portfolio
0.24%
Previous 0.22%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $1,438 - $1,638
9 Added 0.66%
1,374 $250,000
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $187,824 - $211,534
1,365 New
1,365 $211,000
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $11,203 - $13,435
-81 Reduced 4.42%
1,750 $282,000
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $1,610 - $1,847
12 Added 0.66%
1,831 $246,000
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $15,000 - $19,070
-109 Reduced 5.65%
1,819 $279,000
Q1 2022

Aug 15, 2022

BUY
$131.98 - $163.75 $254,457 - $315,710
1,928 New
1,928 $312,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $307B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Coastwise Capital Group, LLC Portfolio

Follow Coastwise Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastwise Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coastwise Capital Group, LLC with notifications on news.